Design and testing of a humanized porcine donor for xenotransplantation.
Ranjith P AnandJacob V LayerDavid HejaTakayuki HiroseGrace LassiterDaniel J FirlViolette B ParagasAdam AkkadSagar ChhangawalaRobert B ColvinRussell J ErnstNicholas EschKristen GetchellAlexandra K GriffinXiaoyun GuoKatherine C HallPaula HamiltonLokesh A KalekarYinan KanAhmad KaradagiFeng LiSusan C LowRudy MathesonClaudia NehringRyo OtsukaMatthew PandelakisRobert A PolicastroRebecca PolsLuis QueirozIvy A RosalesWilliam T SerkinKathryn StiedeToshihide TomosugiYongqiang XueGabriel E ZentnerDavid Angeles-AlboresJ Chris ChaoJuliet N CrabtreeSierra HarkenNicole HinkleTania LemosMailin LiLorena PantanoDenise StevensOmar D SubedarXiaoqing TanShiyi YinImran J AnwarDavid D AufhauserSaverio CapuanoDixon B KaufmanStuart J KnechtleJean KwunDhanansayan ShanmuganayagamJames F MarkmannGeorge M ChurchMike CurtisTatsuo KawaiMichele E YoudWenning QinPublished in: Nature (2023)
Recent human decedent model studies 1,2 and compassionate xenograft use 3 have explored the promise of porcine organs for human transplantation. To proceed to human studies, a clinically ready porcine donor must be engineered and its xenograft successfully tested in nonhuman primates. Here we describe the design, creation and long-term life-supporting function of kidney grafts from a genetically engineered porcine donor transplanted into a cynomolgus monkey model. The porcine donor was engineered to carry 69 genomic edits, eliminating glycan antigens, overexpressing human transgenes and inactivating porcine endogenous retroviruses. In vitro functional analyses showed that the edited kidney endothelial cells modulated inflammation to an extent that was indistinguishable from that of human endothelial cells, suggesting that these edited cells acquired a high level of human immune compatibility. When transplanted into cynomolgus monkeys, the kidneys with three glycan antigen knockouts alone experienced poor graft survival, whereas those with glycan antigen knockouts and human transgene expression demonstrated significantly longer survival time, suggesting the benefit of human transgene expression in vivo. These results show that preclinical studies of renal xenotransplantation could be successfully conducted in nonhuman primates and bring us closer to clinical trials of genetically engineered porcine renal grafts.